Article Details

Galectin Therapeutics Inc (NASDAQ:GALT) Institutional Investor Sentiment Is 1.06

Retrieved on: 2019-04-30 09:52:30

Tags for this article:

Click the tags to see associated articles and topics

Galectin Therapeutics Inc (NASDAQ:GALT) Institutional Investor Sentiment Is 1.06. View article details on hiswai:

Excerpt

<div>Galectin Therapeutics Inc (NASDAQ:GALT) institutional sentiment decreased to 1.06 in 2018 Q4. Its down -0.23, from 1.29 in 2018Q3. The ratio is ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up